Actavis Announces Celebrex Patent Challenge Settlement By: Benzinga via Benzinga April 24, 2014 at 09:20 AM EDT Actavis plc (NYSE: ACT) today announced that it has entered into an agreement with Pfizer, Inc. to settle all outstanding patent ... Read More >> Related Stocks: Actavis Plc